Two unrelated families with variable expression of Fraser syndrome due to the same pathogenic variant in the FRAS1 gene. Issue 4 (30th January 2020)

• Record Type: Journal Article
• Authors: Midro, Alina T.; Stasiewicz‐Jarocka, Beata; Borys, Jan; Hubert, Ewa; Skotnicka, Bożena; Hassmann‐Poznańska, Elżbieta; Sierpińska, Teresa; Panasiuk, Barbara; Schanze, Denny; Zenker, Martin
• Is Part Of: American journal of medical genetics. Volume 182:Issue 4(2020)
• Page Start: 773
• Page End: 779
• Publication Date: 2020-01-30
• Subjects: cryptophthalmos -- cutaneous syndactyly -- FRAS1 c.6963_6964dup pathogenic variant -- Fraser syndrome -- variable expression; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.61495
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: We report on two unrelated families of Polish origin with variable expression of Fraser syndrome (FS; MIM#219000) due to homozygosity for the same pathogenic variant, c.6963_6964dup, of FRAS1 . In one family, the disorder presented with perinatal and prenatal lethality. One affected female from family 2 who was followed‐up for 32 years, represented a relatively favorable long‐term outcome. She displayed the typical craniofacial dysmorphism, including right cryptophthalmos, cutaneous syndactyly, abnormalities of the stomathognatic system, bilateral atresia of the external ear canals resulting in conductive hearing loss, and malformations of the larynx, spleen, kidney, and genitourinary tract. Her intellectual capacities were normal. Our observations illustrate that expression and severity of FS, even when caused by the same pathogenic variant, may be quite different ranging from a lethal disorder to a condition with multiple physical malformations but normal psychomotor development. In addition, we propose that the FRAS1 c.6963_6964dup variant may be a founder mutation in the Polish population. Therefore, it would be reasonable to test specifically for this variant first in any FS1 patient of Polish ancestry.